Inflammatory mediators and NSAID effects

Meloxicam approval in cats is questioned over kidney risk and missing trial data
Examine injectable meloxicam approval for cats, regulatory data discrepancies, acute kidney injury risks, and pharmaceutical sponsorship conflicts in veterinary medicine.
Stability-indicating RP-HPLC method development and validation for quantitative determination of Dexlansoprazole in bulk drug and dual delayed-release capsule
Development and ICH-compliant validation of a stability-indicating RP-HPLC method for quantitative determination of dexlansoprazole in bulk and capsule forms.